-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FomOWAeuIH2e8WvCB5oAYiZfdDlTrTKBmSupTmBZaiSOMIeKTALdNeQIeEKQ+Jkw f1I92jV3oqUEJezJegc9lg== 0000950162-03-001471.txt : 20031105 0000950162-03-001471.hdr.sgml : 20031105 20031105172621 ACCESSION NUMBER: 0000950162-03-001471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20000809 FILED AS OF DATE: 20031105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELAN INTERNATIONAL SERVICES LTD CENTRAL INDEX KEY: 0001002782 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 03980375 BUSINESS ADDRESS: STREET 1: 102 JAMES COURT FLATTS STREET 2: SMITH PARISH FL 04 CITY: BERMUDA STATE: D0 ZIP: 00000 BUSINESS PHONE: 4412929169 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELAN CORP PLC CENTRAL INDEX KEY: 0000737572 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23930 FILM NUMBER: 03980374 BUSINESS ADDRESS: STREET 1: LINCOLN HOUSE LINCOLN PLACE STREET 2: COUNTY WESTMEATH CITY: DUBLIN 2 IRELAND STATE: L2 BUSINESS PHONE: 3537094000 MAIL ADDRESS: STREET 1: LINCOLN HOUSE LINCOLN PLACE STREET 2: EIGHTY PINE STREET CITY: DUBLIN 2 IRELAND STATE: L2 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TARGETED GENETICS CORP /WA/ CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 2066237612 MAIL ADDRESS: STREET 1: 1100 OLIVE WAY STREET 2: STE 100 CITY: SEATTLE STATE: WA ZIP: 98101 4 1 elanform4110503_ex.xml X0201 4 2000-08-09 0 0000921114 TARGETED GENETICS CORP /WA/ TGEN 0000737572 ELAN CORP PLC LINCOLN HOUSE LINCOLN PLACE COUNTY WESTMEATH DUBLIN 2 IRELAND L2 IRELAND 0 0 1 0 0001002782 ELAN INTERNATIONAL SERVICES LTD 102 JAMES COURT FLATTS SMITH PARISH FL 04 BERMUDA D0 00000 0 0 1 0 Common Stock 2000-08-09 4 P 0 382739 13.064 A 2531638 I N/A Common Stock 2003-09-02 4 J 0 3577879 2.09 A 6109517 I N/A Common Stock 2003-09-02 4 J 0 487248 1.95 A 6596765 I N/A Common Stock 2003-09-02 4 J 0 101439 1.88 A 6698204 I N/A Common Stock 2003-09-02 4 J 0 107044 1.19 A 6805248 I N/A Common Stock 2003-09-02 4 J 0 124630 0.96 A 6929878 I N/A Common Stock 2003-09-02 4 J 0 217549 0.83 A 7147427 I N/A Common Stock 2003-09-02 4 J 0 87922 0.65 A 7235349 I N/A Common Stock 2003-09-02 4 J 0 221757 0.57 A 7457106 I N/A Common Stock 2003-09-02 4 J 0 277775 0.49 A 7734882 I N/A Convertible Promissory Note 6.11 2001-09-26 4 P 0 2000000 2000000 A 2003-11-05 Common Stock 327399 2000000 I N/A Convertible Promissory Note 3.70 2002-03-26 4 J 0 120000 120000 A 2003-11-05 Common Stock 32432 2120000 I N/A Convertible Promissory Note 3.78 2002-04-25 4 P 0 2000000 2000000 A 2003-11-05 Common Stock 529801 4120000 I N/A Convertible Promissory Note 2.48 2002-06-28 4 P 0 3000000 3000000 A 2003-11-05 Common Stock 1211509 7120000 I N/A Convertible Promissory Note 1.95 2002-08-09 4 P 0 950000 950000 A 2003-11-05 Common Stock 487248 8070000 I N/A Convertible Promissory Note 1.19 2002-09-26 4 J 0 127200 127200 A 2003-11-05 Common Stock 107044 8197200 I N/A Convertible Promissory Note 0.96 2002-10-25 4 J 0 120000 120000 A 2003-11-05 Common Stock 124630 8317000 I N/A Convertible Promissory Note 0.83 2002-12-28 4 J 0 180000 180000 A 2003-11-05 Common Stock 217549 8497200 I N/A Convertible Promissory Note 0.65 2003-02-09 4 J 0 57000 57000 A 2003-11-05 Common Stock 87922 8554200 I N/A Convertible Promissory Note 0.49 2003-03-26 4 J 0 134832 134832 A 2003-11-05 Common Stock 277775 8689032 I N/A Convertible Promissory Note 1.88 2003-06-28 4 J 0 190800 190800 A 2003-11-05 Common Stock 101439 9007032 I N/A Convertible Promissory Note 2.80 2003-08-09 4 J 0 63420 63420 A 2003-11-05 Common Stock 22650 9070452 I N/A Convertible Promissory Note 2.09 2003-09-02 4 J 0 302934 302934 A 2003-11-05 Common Stock 144779 9373386 I N/A Convertible Promissory Note 6.11 2003-09-02 4 J 0 2000000 2000000 D 2003-11-05 Common Stock 327399 7373386 I N/A Convertible Promissory Note 3.70 2003-09-02 4 J 0 120000 120000 D 2003-11-05 Common Stock 32432 7253386 I N/A Convertible Promissory Note 3.78 2003-09-02 4 J 0 2000000 2000000 D 2003-11-05 Common Stock 529801 5253386 I N/A Convertible Promissory Note 2.48 2003-09-02 4 J 0 3000000 3000000 D 2003-11-05 Common Stock 1211509 2253386 I N/A Convertible Promissory Note 1.95 2003-09-02 4 J 0 950000 950000 D 2003-11-05 Common Stock 487248 1303386 I N/A Convertible Promissory Note 1.19 2003-09-02 4 J 0 127200 127200 D 2003-11-05 Common Stock 107044 1176186 I N/A Convertible Promissory Note 0.96 2003-09-02 4 J 0 120000 120000 D 2003-11-05 Common Stock 124630 1056186 I N/A Convertible Promissory Note 0.83 2003-09-02 4 J 0 180000 180000 D 2003-11-05 Common Stock 217549 876186 I N/A Convertible Promissory Note 0.65 2003-09-02 4 J 0 57000 57000 D 2003-11-05 Common Stock 87922 819186 I N/A Convertible Promissory Note 0.49 2003-09-02 4 J 0 134832 134832 D 2003-11-05 Common Stock 277775 684354 I N/A Convertible Promissory Note 0.57 2003-09-02 4 J 0 127200 127200 D 2003-11-05 Common Stock 221757 557154 I N/A Convertible Promissory Note 1.88 2003-09-02 4 J 0 190800 190800 D 2003-11-05 Common Stock 101439 366354 I N/A Convertible Promissory Note 2.80 2003-09-02 4 J 0 63420 63420 D 2003-11-05 Common Stock 22650 302934 I N/A Convertible Promissory Note 2.09 2003-09-02 4 J 0 302934 302934 D 2003-11-05 Common Stock 144779 0 I N/A Series B Convertible Exchangeable Preferred Stock 3.32 2003-09-02 4 J 0 0 0 A 2003-11-05 Common Stock 0 0 I N/A Convertible Promissory Note 0.57 2003-04-25 4 J 0 127200 127200 A 2003-11-05 Common Stock 221757 8816232 I N/A These securities are or were beneficially owned indirectly by Elan Corporation, plc ("Elan") and directly by its wholly-owned subsidiary, Elan International Services, Ltd. ("EIS"). The Convertible Promissory Note was owned directly by Elan Pharma International Limited, another wholly-owned subsidiary of Elan, but the right to convert the Convertible Promissory Notes and receive Common Stock upon conversion was owned by EIS. The reporting person received the shares of common stock as a prepayment by the Issuer of principal and accrued interest in respect of a Convertible Promissory Note, at a price per share, in respect of each tranche, equal to the lesser of (i) $2.09 (the average of the closing price of the Common Stock for the 60 trading days ending two business days prior to the date of repayment) and (ii) the fixed conversion price for conversion of such tranche at the option of the holder of the conversion right. Each a drawdown of a tranche of the Convertible Promissory Note. Price at which the Convertible Promissory Note was convertible at the option of the holder of the conversion right. In addition, the Convertible Promissory Note was prepayable at the option of the Issuer on a per tranche basis by the issuance to the holder of the conversion right of a number of shares of Common Stock equal to the outstanding principal amount of such tranche and any and all accrued and unpaid interest thereon divided by the lesser of (1) the price equal to the average of the closing price of the Common Stock for the 60 trading days prior to the date of repayment and (2) the conversion price for conversion at the option of the holder of the conversion right. The Convertible Promissory Note was convertible until it was repaid in full. The stated maturity of the Convertible Promissory Note was July 21, 2005. However, it was repaid in full by the Issuer, effective September 2, 2003. Represents interest on the Convertible Promissory Note that was capitalized and added to the principal amount. The principal and accrued interest in respect of the Convertible Promissory Note was prepaid by the Issuer by the issuance of a number of shares of Common Stock equal to, for each tranche, the outstanding principal amount plus accrued interest divided by the lesser of (1) $2.09 and (2) the conversion price for conversion at the option of the holder of the conversion right. The 12,015 shares of Series B Convertible Exchangeable Preferred Stock accrues dividends equal to 7.0% per annum of $1,000.00 per share plus accrued dividends thereon, compounded on a semi-annual basis until July 21, 2005, payable by the issuance of additional shares of Common Stock upon conversion of the Series B Convertible Exchangeable Preferred Stock at a conversion price per share of $3.32, subject to customary antidilution adjustments. As of November 5, 2003, accrued dividends would be convertible into 1,245,215 shares of Common Stock. If the Series B Convertible Exchangeable Preferred Stock is held by the reporting person until at least July 21, 2005, the date on which dividends cease to accrue, accrued dividends will be convertible into 1,851,570 shares of Common Stock. Name: Shane M. Cooke Title: Chief Financial Officer ELAN CORPORATION,PLC Exhibit List Exhibit 99-Joint Filer Information /s/ Shane M. Cooke 2003-11-05 EX-99 3 elanform4110503ex99.txt JOINT FILER INFORMATION Exhibit 99 Joint Filer Information Name: Elan International Services, Ltd. Address: 102 St. James Court Flatts, Smiths FL 04 Bermuda Designated Filer: Elan Corporation, plc Issuer & Ticker Symbol: Targeted Genetics Corporation (TGEN) Date of Earliest Transaction Required to be Reported: 8/9/00 Signature: /s/ Kevin Insley ---------------------------------------- Name: Kevin Insley Title: President ELAN INTERNATIONAL SERVICES, LTD. -----END PRIVACY-ENHANCED MESSAGE-----